Sixera Pharma
Pre-clinicalNetherton syndrome (NS) is a rare genetic disease leading to severe skin inflammation and allergic manifestations. Sixera Pharma is a small biopharmaceutical company, developing treatments for Netherton syndrome.
Founded
2013
Focus
Small Molecules
About
Netherton syndrome (NS) is a rare genetic disease leading to severe skin inflammation and allergic manifestations. Sixera Pharma is a small biopharmaceutical company, developing treatments for Netherton syndrome.
Company Info
TypePrivate
Founded2013
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile